Purchase Order VA580N1889
Award Date 12/14/10
Potential Completion Date 1/14/11
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Scottsdale, AZ 85257, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company. The $3,698.05 contract is for the provision of Regenesis Biomedical's proprietary Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract was not set aside for any preferential contracting vehicle. Regenesis Biomedical has been...
- This is a $7,142.85 firm fixed-price purchase order awarded to Regenesis Biomedical Inc. by the U.S. Department of Veterans Affairs for the Provant Therapy System, a patented medical device for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of June 24, 2011 and does not utilize any set-aside contracting vehicles. Regenesis Biomedical, a for-profit manufacturer, is the prime contractor and has been registered in the System for Award...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 contract is for the Provant Therapy System, a noninvasive regenerative medicine product developed and patented by Regenesis Biomedical. The Provant Therapy System is indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of March 16, 2011. Regenesis...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a for-profit medical technology company. The $4,820.98 contract is for the Provant Therapy System, a patented non-invasive regenerative medicine product indicated for post-operative pain and edema treatment. The contract was awarded under Regenesis Biomedical's existing General Services Administration (GSA) Schedule 65-II-A contract for medical equipment and...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a manufacturer of medical devices. The $4,820.98 contract is for the provision of Regenesis Biomedical's Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract does not utilize any set-aside designations. Regenesis...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The contract is for the provision of Regenesis Biomedical's proprietary Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has a ceiling value of $7,231.47 and was awarded on May 24, 2011, with a completion date of June 24, 2011....
- This is a federal contract award from the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company. The contract is for the provision of Regenesis Biomedical's Provant Therapy System, a non-invasive regenerative medicine product, to VA medical facilities. The award is a $7,142.85 firm fixed-price purchase order with a completion date of February 28, 2011. The contract was not set aside for any preferred contracting vehicle. Regenesis Biomedical has...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 17, to Regenesis Biomedical Inc., a for-profit manufacturer of medical goods. The $7,142.85 contract is for the provision of Regenesis Biomedical's Provant Therapy System, a patented noninvasive regenerative medicine product, for the palliative treatment of post-operative pain and edema. The contract does not utilize any set-aside...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a for-profit medical device manufacturer, for $7,142.85. The contract is for the supply and rental of Regenesis' Provant Therapy System, a non-invasive regenerative medicine product, to VA medical facilities. The contract has an ultimate completion date of May 6, 2011 and was awarded on April 6, 2011. This purchase order was issued under Regenesis' existing General...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a medical device manufacturer. The contract, valued at $3,645.14, is for the provision of Regenesis Biomedical's Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract does not have a set-aside designation. Regenesis Biomedical Inc. is the prime contractor and...